Appropriate goal level for 25-hydroxyvitamin d in cystic fibrosis

Chest

Volumn 140, Issue 2, 2011, Pages 469-474

  West, Natalie E ^a   Lechtzin, Noah ^a   Merlo, Christian A ^a   Turowski, Jason B ^c   Davis, Marsha E ^b   Ramsay, Meghan Z ^a   Watts, Sharon L ^a   Stenner, Shane P ^d   Boyle, Michael P ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ERGOCALCIFEROL; PARATHYROID HORMONE;

25 HYDROXYCOLECALCIFEROL BLOOD LEVEL; ADULT; AGED; ARTICLE; CYSTIC FIBROSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOPENIA; OSTEOPOROSIS; PRIORITY JOURNAL; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

EID: 80051535246     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.10-2114     Document Type: Article

References (18)

1. Aris RM, Merkel PA, Bachrach LK, et al. Guide to bone health and disease in cystic fibrosis. J Clin Endocrinol Metab. 2005;90(3):1888-1896. (Pubitemid 40464064)
2. Cystic Fibrosis Foundation. Annual Data Report to the Center Directors. Bethesda, MD: Cystic Fibrosis Foundation; October 2008. Patient Registry 2007.
3. Boyle MP, Noschese ML, Watts SL, Davis ME, Stenner SE, Lechtzin N. Failure of high-dose ergocalciferol to correct vitamin D deficiency in adults with cystic fibrosis. Am J Respir Crit Care Med. 2005;172(2):212-217. (Pubitemid 40981196)
4. Khazai NB, Judd SE, Jeng L, et al. Treatment and prevention of vitamin D insufficiency in cystic fibrosis patients: comparative efficacy of ergocalciferol, cholecalciferol, and UV light. J Clin Endocrinol Metab. 2009;94(6):2037-2043.
5. Holick MF. Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol. 2009;19(2):73-78.
6. Chapuy MC, Preziosi P, Maamer M, et al. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int. 1997;7(5):439-443. (Pubitemid 27443069)
7. Silverberg SJ. Vitamin D deficiency and primary hyperparathyroidism . J Bone Miner Res. 2007;22(suppl 2):V100-V104. (Pubitemid 351304659)
8. Sahota O, Mundey MK, San P, Godber IM, Lawson N, Hosking DJ. The relationship between vitamin D and parathyroid hormone: calcium homeostasis, bone turnover, and bone mineral density in postmenopausal women with established osteoporosis. Bone. 2004;35(1):312-319. (Pubitemid 38789179)
9. Joly D, Drueke TB, Alberti C, et al. Variation in serum and plasma PTH levels in second-generation assays in hemodialysis patients: a cross-sectional study. Am J Kidney Dis. 2008;51(6):987-995. (Pubitemid 351711603)
10. Garnero P, Sornay-Rendu E, Claustrat B, Delmas PD. Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study. J Bone Miner Res. 2000;15(8):1526-1536. (Pubitemid 30484522)
11. Souberbielle JC, Lawson-Body E, Hammadi B, Sarfati E, Kahan A, Cormier C. The use in clinical practice of parathyroid hormone normative values established in vitamin D-sufficient subjects. J Clin Endocrinol Metab. 2003;88(8):3501-3504. (Pubitemid 37034484)
12. Brown SA, Ontjes DA, Lester GE, et al. Short-term calcitriol administration improves calcium homeostasis in adults with cystic fibrosis. Osteoporos Int. 2003;14(5):442-449. (Pubitemid 36919227)
13. Harkness L, Cromer B. Low levels of 25-hydroxy vitamin D are associated with elevated parathyroid hormone in healthy adolescent females. Osteoporos Int. 2005;16(1):109-113. (Pubitemid 40193226)
14. Hollis BW. Assessment of vitamin D status and definition of a normal circulating range of 25-hydroxyvitamin D. Curr Opin Endocrinol Diabetes Obes. 2008;15(6):489-494.
15. Meunier PJ, Chapuy MC, Arlot ME, Delmas PD, Duboeuf F. Can we stop bone loss and prevent hip fractures in the elderly? Osteoporos Int. 1994;4(suppl 1):71-76.
16. Martínez ME, del Campo MT, Sánchez-Cabezudo MJ, et al. Relations between calcidiol serum levels and bone mineral density in postmenopausal women with low bone density. Calcif Tissue Int. 1994;55(4):253-256. (Pubitemid 24292339)
17. Rosen CJ, Morrison A, Zhou H, et al. Elderly women in northern New England exhibit seasonal changes in bone mineral density and calciotropic hormones. Bone Miner. 1994;25(2):83-92.
18. Thomas MK, Lloyd-Jones DM, Thadhani RI, et al. Hypovitaminosis D in medical inpatients. N Engl J Med. 1998;338(12):777-783. (Pubitemid 28135983)